Yale School of Medicine

Research Studies at Yale

Research Studies at Yale

Family History Study of Alcohol Consumption Using Memantine

For Patients For Researchers

Condition: Alcohol Drinking

What is the purpose of this trial?

The purpose of this study is to evaluate the effects of the study medication, memantine (placebo, 20 mg or 40 mg/day) on alcohol drinking behavior in a laboratory setting in which participants are given an initial drink of alcohol followed by the choice to drink up to 12 more drinks over a three-hour period. We hypothesize that memantine will reduce craving and number of drinks consumed prior to and after exposure to the initial drink of alcohol and during the three hour drinking period. We will also evaluate the influence of family history of alcoholism on the efficacy of memantine in reducing alcohol drinking behavior.


Dates: June 2006 -
Study Status: Recruiting

Who can participate?

Ages Eligible: 21 Years - 50 Years
Gender Eligible: Both

Inclusion Criteria:

  • Ages 21-50
  • Able to read English at 6th grade level or higher and to complete study evaluations
  • Regular alcohol drinker

Exclusion Criteria:

  • Individuals who are seeking alcohol treatment
  • Medical conditions that would contraindicate the use of memantine
  • Regular use of other substances

Sponsors: National Institute on Alcohol Abuse and Alcoholism (NIAAA), Yale University
Phase: Phase 2

First Received: February 27, 2008 
Last Updated: January 22, 2010
Clinicaltrials.gov ID: NCT00630955
Study HIC # 0602001068

Condition: Alcohol Drinking

Interventions: Drug: memantine;
Drug: Memantine;
Drug: Placebo

What is the purpose of this trial?

The purpose of this study is to evaluate the effects of the study medication, memantine (placebo, 20 mg or 40 mg/day) on alcohol drinking behavior in a laboratory setting in which participants are given an initial drink of alcohol followed by the choice to drink up to 12 more drinks over a three-hour period. We hypothesize that memantine will reduce craving and number of drinks consumed prior to and after exposure to the initial drink of alcohol and during the three hour drinking period. We will also evaluate the influence of family history of alcoholism on the efficacy of memantine in reducing alcohol drinking behavior.


Dates: June 2006 -
Study Status: Recruiting

Who can participate?

Ages Eligible: 21 Years - 50 Years
Gender Eligible: Both

Inclusion Criteria:

- Ages 21-50

- Able to read English at 6th grade level or higher and to complete study evaluations

- Regular alcohol drinker

Exclusion Criteria:

- Individuals who are seeking alcohol treatment

- Medical conditions that would contraindicate the use of memantine

- Regular use of other substances


Additional Location

Connecticut

Sponsors: National Institute on Alcohol Abuse and Alcoholism (NIAAA), Yale University
Phase: Phase 2

First Received: February 27, 2008 
Last Updated: January 22, 2010
Clinicaltrials.gov ID: NCT00630955
Study HIC # 0602001068

Participate in this trial

For more information about this trial, contact:

Dana A Cavallo, Ph.D.
2039747607
dana.cavallo@yale.edu

Tricia Dahl, B.A.
2039747599
tricia.dahl@yale.edu


Yale Researcher

Krishnan-Sarin, Suchitra
Principal Investigator  

HIC # 0805003779